Additionally, after the recovery of the PI3K-Akt pathway by the activator, both the proliferation and metastasis ability of PDAC cells were incapable to return to the original level completely, which dropped a hint that LETM2 may adjust tumor progression by means of diverse signaling pathways besides the PI3K-Akt pathway in PDAC. Here, LETM2 is linked to neoplasm.